Here are five highlights:
1. The company reported a 10 percent boost of net sales to $3.5 billion in the fourth quarter of 2017.
2. For the full year, net sales hit $12.4 billion, a 9.9 percent jump over 2016.
3. Domestically, net sales reached $2.5 billion in the fourth quarter and $9.1 billion for the full year of 2017. International sales reached $1 billion in the fourth quarter and $3.4 billion for the full year of 2017.
4. In the fourth quarter of 2017, the following segments grew:
• Neurotechnology and spine— 11.5 percent
• Orthopedics — 8.1 percent
• MedSurg —10.9 percent
5. For the full year of 2017, the segments increased:
• Neurotechnology and spine — 8.2 percent
• Orthopedics — 6.6 percent
• MedSurg — 13.6 percent
6. Neurotechnology and spine net sales increased to $600 million in the fourth quarter and $2.2 billion for the full year of 2017.
7. The orthopedics net sales reached $1.3 billion for the fourth quarter and $4.7 billion for the full year of 2017. Stryker installed 35 Mako robots around the world in the fourth quarter; U.S. knee sales increased 10.5 percent in the quarter.
8. MedSurg net sales rose to $1.6 billion for the fourth quarter and $5.6 billion for the full year of 2017.
9. Stryker anticipates 2017 adjusted net earnings per diluted share to land near the high end of the previously reported range of $6.45 to $6.50.
More articles on devices:
Providence Medical Technology names new executive; reports 2 new studies: 5 insights
Alphatec reports $25M+ in 2017 revenue — 5 points
SeaSpine to see 2017 revenue of $34M+ — 7 observations
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
